TTY Biopharm Company Limited (TPEX:4105)

TTY Biopharm Company Statistics

Total Valuation

TPEX:4105 has a market cap or net worth of TWD 19.15 billion. The enterprise value is 18.19 billion.

Market Cap	19.15B
Enterprise Value	18.19B

Important Dates

The last earnings date was Wednesday, May 14, 2025.

Earnings Date	May 14, 2025
Ex-Dividend Date	Mar 27, 2025

Share Statistics

TPEX:4105 has 248.65 million shares outstanding. The number of shares has increased by 0.04% in one year.

Current Share Class	248.65M
Shares Outstanding	248.65M
Shares Change (YoY)	+0.04%
Shares Change (QoQ)	-0.23%
Owned by Insiders (%)	13.80%
Owned by Institutions (%)	11.02%
Float	187.73M

Valuation Ratios

The trailing PE ratio is 12.30.

PE Ratio	12.30
Forward PE	n/a
PS Ratio	3.15
PB Ratio	2.78
P/TBV Ratio	3.37
P/FCF Ratio	14.90
P/OCF Ratio	13.71
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.69, with an EV/FCF ratio of 14.16.

EV / Earnings	11.66
EV / Sales	2.99
EV / EBITDA	8.69
EV / EBIT	9.55
EV / FCF	14.16

Financial Position

The company has a current ratio of 1.63, with a Debt / Equity ratio of 0.22.

Current Ratio	1.63
Quick Ratio	1.27
Debt / Equity	0.22
Debt / EBITDA	0.90
Debt / FCF	1.18
Interest Coverage	38.25

Financial Efficiency

Return on equity (ROE) is 25.10% and return on invested capital (ROIC) is 11.56%.

Return on Equity (ROE)	25.10%
Return on Assets (ROA)	8.89%
Return on Invested Capital (ROIC)	11.56%
Return on Capital Employed (ROCE)	20.28%
Revenue Per Employee	17.78M
Profits Per Employee	4.56M
Employee Count	342
Asset Turnover	0.58
Inventory Turnover	2.22

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.94% in the last 52 weeks. The beta is -0.13, so TPEX:4105's price volatility has been lower than the market average.

Beta (5Y)	-0.13
52-Week Price Change	-1.94%
50-Day Moving Average	74.52
200-Day Moving Average	74.78
Relative Strength Index (RSI)	53.60
Average Volume (20 Days)	370,814

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4105 had revenue of TWD 6.08 billion and earned 1.56 billion in profits. Earnings per share was 6.26.

Revenue	6.08B
Gross Profit	3.53B
Operating Income	1.50B
Pretax Income	2.03B
Net Income	1.56B
EBITDA	1.69B
EBIT	1.50B
Earnings Per Share (EPS)	6.26

Balance Sheet

The company has 3.23 billion in cash and 1.51 billion in debt, giving a net cash position of 1.72 billion or 6.93 per share.

Cash & Cash Equivalents	3.23B
Total Debt	1.51B
Net Cash	1.72B
Net Cash Per Share	6.93
Equity (Book Value)	6.89B
Book Value Per Share	24.61
Working Capital	2.27B

Cash Flow

In the last 12 months, operating cash flow was 1.40 billion and capital expenditures -111.33 million, giving a free cash flow of 1.28 billion.

Operating Cash Flow	1.40B
Capital Expenditures	-111.33M
Free Cash Flow	1.28B
FCF Per Share	5.17

Margins

Gross margin is 58.01%, with operating and profit margins of 24.61% and 25.66%.

Gross Margin	58.01%
Operating Margin	24.61%
Pretax Margin	33.45%
Profit Margin	25.66%
EBITDA Margin	27.73%
EBIT Margin	24.61%
FCF Margin	21.14%

Dividends & Yields

This stock pays an annual dividend of 4.20, which amounts to a dividend yield of 5.53%.

Dividend Per Share	4.20
Dividend Yield	5.53%
Dividend Growth (YoY)	20.00%
Years of Dividend Growth	2
Payout Ratio	55.79%
Buyback Yield	-0.04%
Shareholder Yield	5.48%
Earnings Yield	8.15%
FCF Yield	6.71%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on August 13, 2014. It was a forward split with a ratio of 1.067.

Last Split Date	Aug 13, 2014
Split Type	Forward
Split Ratio	1.067

Scores

TPEX:4105 has an Altman Z-Score of 4.42.

Altman Z-Score	4.42
Piotroski F-Score	n/a